Evans blue antagonizes both α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1665-1671

  Price, Christopher J ^a   Raymond, Lynn A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CONCANAVALIN A; CYCLOTHIAZIDE; EVANS BLUE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; KAINIC ACID; KAINIC ACID RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE;

ARTICLE; DOSE RESPONSE; HUMAN; HUMAN CELL; LEARNING; MEMORY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SENSORIMOTOR FUNCTION; SYNAPTIC TRANSMISSION;

CELL LINE; EVANS BLUE; HUMANS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 0030448951     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Keller, B. U., M. Blaschke, R. Rivosecchi, M. Hollmann, S. F. Heinemann, and A. Konnerth. Identification of a subunit-specific antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor channels. Proc. Natl. Acad. Sci. USA 90:605-609 (1993).
2. Collingridge, G. L, and W. Singer. Excitatory amino acid receptors and synaptic plasticity. Trends. Pharmacol. Sci. 11:290-296 (1990).
3. Coyle, J. T., and P. Puttfarcken. Oxidative stress, glutamate, and neurodegenerative disorders. Science (Washington D. C.) 262:689-695 (1993).
4. Mayer, M. L., and G. L. Westbrook. The physiology of excitatory amino acids in the vertebrate central nervous system. Prog. Neurobiol. 28:197-276 (1987).
5. Monaghan, D. T., R. J. Bridges, and C. W. Cotman. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:365-402 (1989).
6. Nakanishi, S. Molecular diversity of glutamate receptors and implications for brain function. Science (Washington D. C.) 258:597-603 (1992).
7. Seeburg, P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:359-365 (1993).
8. Hollmann, M., and S. Heinemann. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:31-108 (1994).
9. Burnashev, N. Recombinant ionotropic glutamate receptors: functional distinctions imparted by different subunits. Cell. Physiol. Biochem. 3:318-331 (1993).
10. Wilding, T. J., and J. E. Huettner. Differential antagonism of α-amino-3-hydroxy-S-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol. 47:582-587 (1995).
11. Wilding, T. J., and Huettner, J. E. Antagonist pharmacology of kainate-and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors. Mol. Pharmacol. 49:540-546 (1996).
12. Huettner, J. E. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 5:255-266 (1990).
13. Egebjerg, J., B. Bettler, I. Hermans-Borgmeyer, and S. Heinemann. Cloning of cDNA for a glutamate receptor subunit activated by kainate but not by AMPA. Nature (Lond.) 351:745-748 (1991).
14. Partin, K. M., D. K. Patneau, C. A. Winters, M. L. Mayer, and A. Buonauno. Selective modulation of deseneitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11:1069-1082 (1993).
15. Yamada, K., and C. -M. Tang. Benzothiadiazines inhibit rapid glutamate receptor desensitization and enhance glutamatergic eynaptic currents. J. Neurosci. 13:3904-3915 (1993).
16. Chen, C., and H. Okayama. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752 (1987).
17. Sommer, B., K. Keinäen, T. A. Verdoorn, W. Wisden, N. Burnashev, A. Herb, M. Köhler, T. Takagi, B. Sakmann, and P. H. Seeburg. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science (Washington D. C.) 249:1580-1585 (1990).
18. Raymond, L. A., C. D. Blackstone, and R. L. Huganir. Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase. Nature (Lond.) 361:637-641 (1993).
19. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pfluegers Arch. Eur. J. Physiol. 391:85-100 (1981).
20. Honoré, T., S. N. Davies, J. Drejer, E. J. Fletcher, P. Jacobsen, D. Lodge, and F. E. Nielsen. Quinoxalinediones. Potent competitive non-NMDA glutamate receptor antagonists. Science (Washington D. C.) 241:701-703 (1988).
21. Roche, K. W., L. A. Raymond, C. Blackstone, and R. L. Huganir. Transmembrane topology of the glutamate receptor subunit GluR6. J. Biol. Chem. 269:11679-11682 (1994).
22. Ruano, D., B. Lambolez, J. Rossier, A. V. Paternain, and J. Lerma. Kainate receptor subunits expressed in single cultured hippocampal neurons: molecular and functional variants by RNA editing. Neuron 14:1009-1017 (1995).
23. Goldstein, I. J. Studies on the combining sites of concanavalin A. Adv. Exp. Med. Biol. 55:35-53 (1975).
24. Mathers, D. A., and P. N. R. Usherwood. Concanavalin A blocks desensitization of glutamate receptors on insect muscle fibres. Nature (Lond.) 259:409-411 (1976).
25. Partin, K. M., D. K. Patneau, and M. L. Mayer. Cyclothiazide differentially modulates desensitization of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol. 46:129-138 (1994).
26. Partin, K. M., D. Bowie, and M. L. Mayer. Structural determinants of allosteric regulation in alternatively spliced AMPA receptors. Neuron 14: 833-843 (1995).
27. Zorumski, C. F., K. A. Yamada, M. T. Price, and J. W. Olney. A benzodiazepine site associated with the non-NMDA glutamate receptor. Neuron 10:61-67 (1993).
28. Johansen, T. H., A. Chaudhary, and T. A. Verdoorn. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol. 48:946-955 (1995).
29. Yamada, K. A. Cyclothiazide interactions with AMPA and kainate receptor antagonists. Soc. Neurosci. Abstr. 2:1264 (1995).
30. Donevan, S. D., and M. A. Rogawski. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10:51-59 (1993).
31. Lomeli, H., J. Mosbacher, T. Melcher, T. Höger, J. R. P. Geiger, T. Kuner, H. Monyer, M. Higuchi, A. Bach, and P. H. Seeburg. Control of kinetic properties of AMPA receptor channels by nucleus RNA editing. Science (Washington D.C.) 266:1709-1713 (1994).
32. Mosbacher, J., R. Schoepfer, H. Monyer, N. Burnashev, P. Seeburg, and J. P. Ruppersberg. A molecular determinant for submillisecond desensitization in glutamate receptors. Science (Washington D. C.) 266:1059-1062 (1994).
33. Leßmann, V., K. Gottmann, and H. D. Lux. Evans blue reduces macroscopic desensitization of non-NMDA receptor mediated currents and prolongs excitatory postsynaptic currents in cultured rat thalamic neurons. Neurosci. Lett. 146:13-16 (1992).